BSE filing, NSE: CONCORD. Summary written from the filing by ALFA Finder's alert engine.
Concord Drugs Ltd: key numbers
- Share price
- ₹64.01
- Market cap
- ₹84.33 Cr
- Revenue (annual)
- ₹78.74 Cr
- Net profit (annual)
- ₹1.06 Cr
- P/E (TTM)
- 41.1×Sector 46.1×
- Promoter holding
- 45.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Concord Drugs Ltd
All →Concord Drugs Other Announcement
Concord Drugs Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
Concord Drugs Annual General Meeting
Concord Drugs Limited held its 31st Annual General Meeting on September 30, 2026. The meeting covered adoption of financial statements, director appointments, and auditor re-appointment.
Concord Drugs Other Announcement
Concord Drugs Limited is notifying shareholders about the annual report web-link as per Regulation 36(1)(b). Shareholders are urged to update their email addresses.
Concord Drugs Annual Report
Concord Drugs Limited submitted its 31st Annual Report for FY 2025-26 and notice of the 31st Annual General Meeting scheduled for 30th September 2026.
Concord Drugs Annual General Meeting
Concord Drugs approved the notice for its 31st AGM on September 30, 2026. The board also finalized director re-appointments and set book closure dates.
Concord Drugs Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 1000.0% YoY
Concord Drugs Ltd reported revenue from operations of ₹20.9 Cr (+53.7% YoY) and net profit of ₹1.1 Cr (+1000.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.1 Cr · +1000.0% YoY
Other board meeting date announcements
All →RateGain Travel Technologies Board Meeting Date
RateGain Travel Technologies will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window closes from 1 October 2026 until 48 hours after results.
Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.